Is the estrogen patch safer than pills? (Transdermal vs oral)

When the experts express a preference on how to take estrogen, it points the same direction: transdermal — a patch, gel, or spray — over oral pills. The reason is mechanical. Oral estrogen is absorbed through the gut and passes through the liver first (hepatic first-pass metabolism), which raises clotting factors. That's what drives oral estrogen's associations with venous thromboembolism (VTE), stroke, and gallbladder disease.

Transdermal estradiol is absorbed through the skin and largely bypasses that first-pass effect, so it carries substantially less clotting risk. Attia describes the modern, evidence-aligned approach as estradiol patches paired with micronized progesterone (or a progesterone IUD) for women with a uterus. Hyman favors transdermal over oral to reduce inflammation and clot risk, and prefers bioidentical estradiol over older synthetic combinations like Premarin/Provera. Via Dr. Mary Claire Haver, Huberman makes the same point explicitly — transdermal carries less clot risk than oral.

Two related distinctions matter. First, if you have a uterus, systemic estrogen is paired with progesterone to protect the endometrium — this is why the FDA kept the endometrial-cancer warning specifically for systemic estrogen-only therapy. Second, the experts warn against fringe practices that get marketed alongside legitimate HRT: compounded "bioidentical" pellets, saliva-hormone testing, and unproven anti-aging hormone schemes. Get care from a qualified menopause specialist, not a wellness sales funnel.

As always, route, formulation, and dose are physician decisions — this describes what the experts say on video about why transdermal is generally preferred, not a prescription.